The CHMP positive opinion will now be reviewed by the European Commission (EC)as part of the established approval process, and a decision on granting the marketing authorisation in EU member countries and European Economic Area (EEA) member states such as Norway, Iceland, and Liechtenstein would be taken after this, it said.
from Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/GMXBPWK
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment